SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Is the Mo-99 shortage over? Nordion, MURR, General Atomics form production partnership The Sterigenics International subsidiary will focus on LEU Mo-99 production process

Olympus facing suits for infection and death of patients at UCLA Olympus Corp. of the Americas is facing suits for infections allegedly stemming from use of its duodenoscopes

DoD is homing in on a suitor for its $11 billion EHR contract Interested parties emphasize "fee for value" in selection process

Patient satisfaction little moved by fancy hospital design: study $200 billion spent on renovation projects, but is it worth it?

New Product Showcase This month's roundup of the latest industry products.

Young child is first fatality in Germany's measles outbreak Berlin has recorded more than 570 measles diagnoses since October

Toshiba to unveil Aquilion Lightning CT at ECR 2015 16-row helical CT with 0.5mm element for isotropic imaging

Medical identity fraud affected two million American adults last year Increased use of EHRs contributing to the problem

Medical World Americas announces sponsorship from major industry players GE, and others, are backing the second annual conference and expo

Comparing options for stereotactic radiosurgery Comparing options for stereotactic radiosurgery

Dr. Phillip Gray, lead author of the study
on prostate cancer patients
treated with proton therapy,
3-D CRT, and IMRT, during a briefing

Proton therapy's benefits for the treatment of prostate cancer on display at ASTRO 2012

by Loren Bonner , DOTmed News Online Editor
The American Society of Radiation Oncology's (ASTRO) annual meeting, held last week in Boston, was a testament to the growing body of evidence supporting proton beam therapy for the treatment of men with prostate cancer.

Several studies were presented at the conference that assessed prostate cancer patients' quality of life and toxicities following treatment with proton beam therapy. All of the studies reported favorable outcomes, especially for safeguarding men's bowel and urinary functions.

Story Continues Below Advertisement

Dunlee - Design, Manufacture & Distribution of CT & Rad X-Ray Products

Dunlee manufactures replacement tubes for more CT systems than any other company in the industry. Philips, GE, Picker, Shimadzu, Siemens, Elscint or Toshiba replacement tubes for all popular systems. Call 800.238.3780



Quality of life

One of the larger data sets presented was a multi-institutional study of 1,090 men treated at the MD Anderson Proton Therapy Center, Scripps Proton Therapy Center, Loma Linda Medical Center, Massachusetts General Hospital, and the University of Florida Proton Therapy Institute. It found that patient-reported quality of life scores equaled healthy men. Patients, who averaged 65 years old, completed the Expanded Prostate Cancer Index Composite (EPIC) survey up to 10 years following proton beam therapy treatment. Prostate cancer patients scored 89.8 for urinary quality and 92.7 for bowel functions, compared with scores of 89.5 and 92.4, respectively, for healthy men. The survey used a scoring system of 1 (poor) to 100 (perfect).

Another study compared quality of life scores from prostate cancer patients who received proton beam therapy to those who were treated with two other common radiation therapy modalities: intensity modulated radiation therapy (IMRT) and 3-D conformal (3-D CRT). One of the main takeaways from this study, authors concluded, was that proton beam therapy appeared to be associated with better early bowel quality of life compared to 3D-CRT and IMRT. The study evaluated 123 patients treated with 3D-CRT from 1994-2000 at Harvard Affiliated Hospitals; 153 patients treated with IMRT from 2003-2006 at 9 hospitals; and 94 patients treated with proton beam therapy from 2004-2008 at Massachusetts General Hospital.

ProCure's findings

While all studies to date on the effectiveness of proton beam therapy treatment have been conducted at academic medical centers, the for-profit chain ProCure, which has been opening centers around the country, has also been compiling evidence for proton beam therapy. The first ProCure center opened in Oklahoma City in 2009, and from day one, it established a patient database and opened a registry study.

Dr. Sameer Keole, a radiation oncologist at ProCure Proton Therapy Center in Oklahoma City, presented results from 76 prostate cancer patients who were treated at the facility.

Continue reading Proton therapy's benefits for the treatment of prostate cancer on display at ASTRO 2012...
  Pages: 1 - 2 >>

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED